Skip to content
  • Tuesday, 27 October 2026
  • 4:40 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • BrowserAct Introduces Next-Generation AI Web Scrapping Platform to Solve Data Collection Bottlenecks for Enterprise Teams
Data Science & Bioinformatics

BrowserAct Introduces Next-Generation AI Web Scrapping Platform to Solve Data Collection Bottlenecks for Enterprise Teams

Evan Lee Salim Oct 1, 2026 0

In the fast-paced landscape of modern digital commerce and market research, the ability to collect, process, and analyze real-time web…

Read More
Biotech & Genetic Research

AI and Machine Learning Poised to Revolutionize Antibody Therapeutics, Experts Declare as Landmark Journal Collection Concludes

Jia Lissa Jul 23, 2026 0

The landscape of antibody therapeutic development is undergoing a profound transformation, driven by the accelerating integration of artificial intelligence (AI)…

Read More
Biotech & Genetic Research

Comprehensive Infographic Illuminates Advances in Spatial Data Collection: Comparing Imaging, Capture, and Novel Donation-Based Sequencing Techniques

Jia Lissa May 8, 2026 0

The landscape of biological research is undergoing a profound transformation, driven by an increasing demand to understand molecular processes within…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million to Revolutionize Blood Collection with Autonomous Robotic Phlebotomy, Poised for Global Expansion

Reynand Amr Wu Mar 22, 2026 0

Vitestro, a pioneering Dutch medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million Series B Funding to Revolutionize Blood Collection with Autonomous Robotics

Reynand Amr Wu Mar 14, 2026 0

Vitestro, a pioneering Dutch medical technology firm, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…

Read More
TWiV 1284: Clinical update with Dr. Daniel GriffinLilly’s retatrutide shows 28.3% weight loss, but increased side effectsInnovative Bioengineered Bone Marrow-on-a-Chip Platform Replicates Human Hematopoietic Systems to Revolutionize Drug Development and Space ExplorationEU Strikes Landmark Deal on Critical Medicines Act to Fortify Pharmaceutical Sector and Ensure Patient Supply
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ